A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

This publication has 42 references indexed in Scilit:

• Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
  British Journal of Cancer, 2001
• Interpretation and Quantification of Immunostains
  The American Journal of Surgical Pathology, 2001
• p21 and p53 in ovarian carcinoma
  Cancer, 2001
• The role of molecular biology in understanding ovarian cancer initiation and progression
  International Journal of Gynecologic Cancer, 2001
• A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes
  International Journal of Cancer, 2001
• Does paraaortic lymphadenectomy have a benefit in the treatment of ovarian cancer that is apparently confined to the ovaries?
  European Journal Of Cancer, 2001
• ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation
  International Journal of Cancer, 2000
• The onset and extent of genomic instability in sporadic colorectal tumor progression
  Proceedings of the National Academy of Sciences, 1999
• Expression of Epidermal Growth Factor and Androgen Receptors in Ovarian Cancer
  Gynecologic Oncology, 1997
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981